Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Mitigating bias in pharmaceutical R&D decision-making

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature Reviews Drug Discovery 21, 874-875 (2022)



The authors would like to thank K. Smietana, S. Visser, R. Lalonde and B. Weber for their inputs while participating in the earlier stages of this project, as well as B. Metzler with her diligent input on the manuscript writing. Special thanks go to the anonymous survey participants who gave their input and often provided insights via their additional comments.

Supplementary Information

  1. Supplementary Boxes

Competing Interests

The authors declare no competing interests.

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links